James WarrenVP Pharmceutical Development at Ultragenyx
Agenda Sessions
CMC Platform Development and Late Stage Considerations for AAV Gene Therapy Products
, 1:40pmView Session
This site is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
CMC Platform Development and Late Stage Considerations for AAV Gene Therapy Products